Internet Posting of Information Treace routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.treace.com. The Company encourages ...

Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.

Full commercialization of the Nanoplasty™ 3D MIS Bunion Correction ™ System is anticipated to ... some of which cannot be predicted or quantified. Factors that could cause actual results or other ...

"The goal of a compression sock for plantar fasciitis is to provide better support for the arch of the foot," Richard H.